Blood Flow Remodels Growing Vasculature During Vascular Endothelial Growth Factor Gene Therapy and Determines Between Capillary Arterialization and Sprouting Angiogenesis
暂无分享,去创建一个
S. Ylä-Herttuala | O. Gröhn | T. Liimatainen | T. Heikura | P. Korpisalo | I. Kholová | M. Ordén | T. Rissanen | J. Markkanen | A. D. de Goede
[1] H. Kauczor,et al. Assessment of Skeletal Muscle Perfusion Using Contrast‐Enhanced Ultrasonography , 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[2] P. Lloyd,et al. VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats. , 2005, American journal of physiology. Heart and circulatory physiology.
[3] C. D. de Korte,et al. Modeling ultrasound contrast measurement of blood flow and perfusion in biological tissue. , 2005, Ultrasound in medicine & biology.
[4] Thomas Schmitz-Rixen,et al. Elevated Fluid Shear Stress Enhances Postocclusive Collateral Artery Growth and Gene Expression in the Pig Hind Limb , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[5] J. Hartikainen,et al. Adenoviral Catheter-Mediated Intramyocardial Gene Transfer Using the Mature Form of Vascular Endothelial Growth Factor-D Induces Transmural Angiogenesis in Porcine Heart , 2004, Circulation.
[6] J B Fowlkes,et al. Analysis of refill curve shape in ultrasound contrast agent studies. , 2004, Medical physics.
[7] H. Blau,et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. , 2004, The Journal of clinical investigation.
[8] W. Schaper,et al. Factors Regulating Arteriogenesis , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[9] J. Hartikainen,et al. Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia: Phase II Results of the Kuopio Angiogenesis Trial (KAT) , 2003, Circulation.
[10] K. Alitalo,et al. Gene transfer as a tool to induce therapeutic vascular growth , 2003, Nature Medicine.
[11] R. Kauppinen,et al. VEGF-D Is the Strongest Angiogenic and Lymphangiogenic Effector Among VEGFs Delivered Into Skeletal Muscle via Adenoviruses , 2003, Circulation research.
[12] Walter L Murfee,et al. Enhanced Smooth Muscle Cell Coverage of Microvessels Exposed to Increased Hemodynamic Stresses In Vivo , 2003, Circulation research.
[13] L. Zentilin,et al. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[14] H. Blau,et al. Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[15] O. Topolcan,et al. Diagnostic role of markers dipeptidyl peptidase IV and thyroid peroxidase in thyroid tumors. , 2003, Anticancer research.
[16] J. Jurvelin,et al. Kinetics of a US contrast agent in benign and malignant adnexal tumors. , 2003, Radiology.
[17] R. Kauppinen,et al. Fibroblast growth factor‐4 induces vascular permeability, angiogenesis, and arteriogenesis in a rabbit hind limb ischemia model , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] E. Maltezos,et al. Down-regulation of intestinal-type alkaline phosphatase in the tumor vasculature and stroma provides a strong basis for explaining amifostine selectivity. , 2002, Seminars in oncology.
[19] B. Weinstein,et al. sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. , 2002, Developmental cell.
[20] Thomas N. Sato,et al. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF) , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[21] W. McDicken,et al. In vitro acoustic characterisation of four intravenous ultrasonic contrast agents at 30 MHz. , 2002, Ultrasound in medicine & biology.
[22] P. Carmeliet,et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro‐angiogenic therapy , 2002, The EMBO journal.
[23] Ingeborg Stalmans,et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. , 2002, The Journal of clinical investigation.
[24] C. Zarins,et al. Blood Flow Decrease Induces Apoptosis of Endothelial Cells in Previously Dilated Arteries Resulting From Chronic High Blood Flow , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[25] T. Ichikawa,et al. Perfusion MR imaging with a superparamagnetic iron oxide using T2-weighted and susceptibility-sensitive echoplanar sequences: evaluation of tumor vascularity in hepatocellular carcinoma. , 1999, AJR. American journal of roentgenology.
[26] Y. Ni,et al. Comparison of iron oxide particles (AMI 227) with a gadolinium complex (Gd‐DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) for both phantom and rat brain at 1.5 tesla , 1999, Journal of magnetic resonance imaging : JMRI.
[27] B. Saltin,et al. Skeletal muscle blood flow in humans and its regulation during exercise. , 1998, Acta physiologica Scandinavica.
[28] O Nalcioglu,et al. Tumor characterization with dynamic contrast–enhanced MRI using mr contrast agents of various molecular weights , 1998, Magnetic resonance in medicine.
[29] E. Brogi,et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.
[30] F. Hansen-Smith,et al. Expression of muscle capillary alkaline phosphatase is affected by hypoxia. , 1992, Journal of applied physiology.
[31] M. Grim,et al. Alkaline phosphatase and dipeptidylpeptidase IV staining of tissue components of skeletal muscle: a comparative study. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[32] B L Langille,et al. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. , 1986, Science.
[33] A. Ziada,et al. The effect of long-term vasodilatation on capillary growth and performance in rabbit heart and skeletal muscle. , 1984, Cardiovascular research.
[34] Z. Lojda. Studies on dipeptidyl(amino)peptidase IV (glycyl-proline naphthylamidase) , 1979, Histochemistry.
[35] Dian Feng,et al. Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor , 2000, Laboratory Investigation.
[36] J. Correas,et al. Infusion versus bolus of an ultrasound contrast agent: in vivo dose-response measurements of BR1. , 2000, Investigative radiology.
[37] J. Spaan,et al. Shear stress is not sufficient to control growth of vascular networks: a model study. , 1996, The American journal of physiology.
[38] P A Heidenreich,et al. In vitro calculation of flow by use of contrast ultrasonography. , 1993, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.